Injective Jumps 30% to $9.35 on October 16 After CEO White House, SEC Meetings
On October 16, 2026, Injective (INJ) surged 30% in 24 hours to an intraday high of $9.35, driven by three key catalysts. CEO Eric Chen met White House, SEC and CFTC officials in Washington on October 14, positioning Injective at the regulatory table for U.S. tokenization rules. The token is
INJ17.66%
GateNews·20m ago
